media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Panacea Biotec Ltd.
( in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
      
INCOME     
Revenue From Operations [Net]456.92659.22617.65537.19452.27
Other Operating Revenues3.032.017.166.884.43
Total Operating Revenues459.95661.23624.81544.06456.70
      
Other Income51.6610.979.9829.694.48
Total Revenue511.61672.20634.78573.75461.18
      
EXPENSES     
Cost Of Materials Consumed211.03281.25167.76179.30125.87
Purchase Of Stock-In Trade7.2629.9331.2610.719.19
Changes In Inventories Of FG,WIP And Stock-In Trade34.37-48.975.61-33.2237.18
Employee Benefit Expenses126.48182.94156.17142.32147.08
Finance Costs4.44180.84185.34173.98104.83
Depreciation And Amortisation Expenses39.1243.6645.5943.2254.00
Other Expenses178.76229.95187.37213.59268.57
Total Expenses601.47899.60779.11729.90746.72
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-89.86-227.40-144.32-156.15-285.54
      
Exceptional Items102.661676.210.00-15.40334.01
Profit/Loss Before Tax12.811448.81-144.32-171.5548.47
      
Tax Expenses-Continued Operations     
Current Tax2.56400.732.3239.967.55
Deferred Tax43.99-29.82-0.37-23.320.16
Total Tax Expenses46.55370.911.9616.647.71
Profit/Loss After Tax And Before ExtraOrdinary Items-33.751077.90-146.28-188.1940.76
      
Profit/Loss From Continuing Operations-33.751077.90-146.28-188.1940.76
      
Profit/Loss From Discontinuing Operations0.000.00-0.78-6.12-2.39
Total Tax Expenses Discontinuing Operations0.000.000.670.310.85
Net Profit/Loss From Discontinuing Operations0.000.00-1.46-6.44-3.24
Profit/Loss For The Period-33.751077.90-147.74-194.6337.52
      
Minority Interest0.51-0.02-0.040.030.06
Share Of Profit/Loss Of Associates0.000.000.080.330.15
Consolidated Profit/Loss After MI And Associates-33.241077.89-147.70-194.2737.73
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-5.43175.98-24.11-31.726.15
Diluted EPS (Rs.)-5.43175.98-24.11-31.726.15
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
INCOME 
Revenue From Operations [Net]456.92
Other Operating Revenues3.03
Total Operating Revenues459.95
Other Income51.66
Total Revenue511.61
EXPENSES 
Cost Of Materials Consumed211.03
Purchase Of Stock-In Trade7.26
Changes In Inventories Of FG,WIP And Stock-In Trade34.37
Employee Benefit Expenses126.48
Finance Costs4.44
Depreciation And Amortisation Expenses39.12
Other Expenses178.76
Total Expenses601.47
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-89.86
Exceptional Items102.66
Profit/Loss Before Tax12.81
Tax Expenses-Continued Operations 
Current Tax2.56
Deferred Tax43.99
Total Tax Expenses46.55
Profit/Loss After Tax And Before ExtraOrdinary Items-33.75
Profit/Loss From Continuing Operations-33.75
Profit/Loss From Discontinuing Operations0.00
Total Tax Expenses Discontinuing Operations0.00
Net Profit/Loss From Discontinuing Operations0.00
Profit/Loss For The Period-33.75
Minority Interest0.51
Share Of Profit/Loss Of Associates0.00
Consolidated Profit/Loss After MI And Associates-33.24
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)-5.43
Diluted EPS (Rs.)-5.43